Advances in Cancer Research
- 1st Edition, Volume 85 - September 30, 2002
- Latest edition
- Editors: George F. Vande Woude, George Klein
- Language: English
Researchers and students in the basic and clinical science of cancer biology and oncology, genetics, immunology, pharmacology, cell and molecular biology.
The Von Hippel-Lindau Tumor Suppressor Complex and Regulation of Hypoxia-Inducible Transcription. Retinoblastoma Tumor Suppressor and Genome Stability.
The Abl Family Kinases: Mechanisms of Regulation and Signaling.
Cellular Immunity to the Her-2/neu Proto-oncogene.
A New Challenge for Successful Immunotherapy by Tumors That Are Resistant to Apoptosis: Two Complementary Signals to Overcome Cross-Resistance.
Cell Volume and Ion Changes During Apoptotic Cell Death.
Mitochondria and Apoptosis: New Therapeutic Targets.
The Abl Family Kinases: Mechanisms of Regulation and Signaling.
Cellular Immunity to the Her-2/neu Proto-oncogene.
A New Challenge for Successful Immunotherapy by Tumors That Are Resistant to Apoptosis: Two Complementary Signals to Overcome Cross-Resistance.
Cell Volume and Ion Changes During Apoptotic Cell Death.
Mitochondria and Apoptosis: New Therapeutic Targets.
- Edition: 1
- Latest edition
- Volume: 85
- Published: September 30, 2002
- Language: English
GV
George F. Vande Woude
Affiliations and expertise
Director, Van Andel Research Institute, Grand Rapids, MI, USA
NCI-Frederick Cancer Research Facility Frederick, Maryland
ABL-Basic Research Program, NCI-Frederick Cancer Research and Development Center, Frederick, MarylandGK
George Klein
Affiliations and expertise
Karolinska Insitutet, Stockholm, SwedenRead Advances in Cancer Research on ScienceDirect